Comprehensive clinical evidence

Stay up to date on the latest clinical evidence from Medtronic. Key summaries demonstrate the efficacy of the CoreValve™/Evolut™ TAVR platform.



Real-world results

The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.  

Explore our STS/ACC TVT Registry™* data that supports the excellent clinical performance seen in our trials.



EXPAND TAVR II Pivotal Trial

The purpose of the EXPAND TAVR II Pivotal Trial is to explore the treatment of moderate aortic stenosis (AS) with early aortic valve replacement (AVR) before AS becomes severe. This can lead to preservation of cardiac function, prevention of further deterioration in cardiac function, and prevention of death in some patients.


Connect with us on social.

LinkedIn: Medtronic Cardiac and Vascular

Get support.

Reach out to CardioVascular LifeLine Tech Support with questions.

Phone: 877-526-7890


Related products